Echogenicity Enhances Risk Assessment of Lesions on MP-MRI for Clinically Significant Prostate Cancer
dc.contributor.author | Wegner, Garret | |
dc.contributor.author | Khan, Amir | |
dc.contributor.author | Panagos, MIchael | |
dc.contributor.author | Wang, Shu | |
dc.contributor.author | Van Besien, Alexa J. | |
dc.contributor.author | Naslund, Michael | |
dc.contributor.author | Siddiqui, M. Minhaj | |
dc.contributor.author | Panagos, Michael | |
dc.date.accessioned | 2024-05-17T17:22:06Z | |
dc.date.available | 2024-05-17T17:22:06Z | |
dc.date.issued | 2024-05-03 | |
dc.identifier.uri | http://hdl.handle.net/10713/22106 | |
dc.description | American Urological Association Annual Conference. May 3, 2024. | en_US |
dc.description.abstract | Multiparametric Magnetic Resonance Imaging (MP-MRI)/ ultrasound fusion guided biopsy (targeted biopsy) is emerging as an alternative diagnostic tool for Prostate cancer (PCa) in addition to historically used Transrectal Ultrasound-guided (TRUS) biopsy. Echogenicity observed during the fusion of MRI and ultrasound images may be associated with the detection of clinically significant prostate cancer in targeted biopsy of MP-MRI lesions. | en_US |
dc.language.iso | en_US | en_US |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | en_US |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject.lcsh | Prostate--Cancer | en_US |
dc.subject.mesh | Magnetic Resonance Imaging | en_US |
dc.subject.mesh | Multiparametric Magnetic Resonance Imaging | en_US |
dc.subject.mesh | Ultrasonography | en_US |
dc.title | Echogenicity Enhances Risk Assessment of Lesions on MP-MRI for Clinically Significant Prostate Cancer | en_US |
dc.type | Poster/Presentation | en_US |
refterms.dateFOA | 2024-05-17T17:22:07Z |